首页|DCE-MRI预测乳腺癌NAC治疗后病理完全缓解的可行性研究

DCE-MRI预测乳腺癌NAC治疗后病理完全缓解的可行性研究

扫码查看
目的 分析动态增强磁共振(DCE-MRI)预测乳腺癌新辅助化疗(NAC)治疗后病理完全缓解(pCR)的可行性.方法 收集2018年8月到2022年12月本院收治的经NAC治疗乳腺癌患者120例,均在根治手术前行NAC治疗,术后以Miller & Payne改良病理反应标准评估患者治疗后pCR情况.对比化疗前后以及pCR组与未缓解组DCE-MRI定量参数值(Ktrans、Ve、Kep);探究影响乳腺癌NAC治疗后病理完全缓解相关因素,通过绘制ROC曲线,分析DCE-MRI预测乳腺癌NAC治疗后pCR的效能.结果 120例患者Miller&Payne分级显示,Ⅰ~Ⅲ级者86例(未缓解组),Ⅳ~Ⅴ级者34例(pCR组);NAC治疗后患者Ktrans、Ve、Kep值均明显低于NAC治疗前(P<0.05);pCR组Ktrans、Ve、Kep值均明显低于未缓解组(P<0.05);pCR组与未缓解组在年龄、肿瘤直径、生育情况、病理类型、NAC治疗方案、分子分型中比较,差异无统计学意义(P>0.05),pCR组TNM分期Ⅱ期占比高于未缓解组(88.24%vs 12.79%)(P<0.05);以组别(pCR组及未缓解组)为因变量,以TNM分期、Ktrans、Ve、Kep为自变量,进行Logistic回归分析结果显示:TNM分期[95%CI:(1.076~2.611)]、Ktrans[95%CI:(1.120~1.678)]、Ve[95%CI:(1.253~2.479)]、Kep[95%CI:(1.295~1.963)]为影响pCR的独立危险因素(P<0.01);ROC结果显示:Ktrans+Ve+Kep对pCR预测AUC值为0.879,高于Ktrans、Ve、Kep三者单独检测(P<0.05).结论 NAC治疗前后DCE-MRI定量参数Ktrans、Ve、Kep值存在明显变化,于NAC治疗后pCR患者中呈现更低水平;通过获取DCE-MRI的影像数据,以预测NAC治疗后pCR的可行性高,有益于后续指导临床完善个体化治疗方案.
Feasibility Study of DCE-MRI in Predicting Pathological Complete Remission of Breast Cancer after NAC Treatment
Objective To analyze the feasibility of dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI)in predicting pathological complete remission(pCR)after neoadjuvant chemotherapy(NAC)for breast cancer.Methods A total of 120 patients with breast cancer treated with NAC from August 2018 to December 2022 in our hospital were collected.All patients were treated with NAC before radical surgery.After surgery,the pCR status of patients after treatment was evaluated by Miller&Payne's modified pathological reaction standard.Compare the quantitative parameter values of DCE-MRI(Ktrans,Ve,Kep)before and after chemotherapy,as well as between the pCR group and the unrelieved group;To explore the factors related to pathological complete remission after NAC treatment for breast cancerand analyze the efficacy of DCE-MRI in predicting pCR after NAC treatment for breast cancer by drawing Receiver operating characteristicResuts The Miller&Payne grading of 120 patients showed that there were 86 cases of grade Ⅰ to Ⅲ(unrelieved group)and 34 cases of grade Ⅳ to Ⅴ(pCR group);The Ktrans,Ve,and Kep values of patients after NAC treatment were significantly lower than those before NAC treatment(P<0.05);The Ktrans,Ve,and Kep values of patients in the pCR group were significantly lower than those in the unrelieved group(P<0.05).There was no statistically significant difference between the pCR group and the unrelieved group in terms of age,tumor diameter,fertility status,pathological type,NAC treatment plan,and molecular typing(P>0.05),The proportion of patients with TNM stage Ⅱ in the pCR group was higher than that in the unrelieved group(35.29%vs 12.79%)(P<0.05);Logistic regression analysis was conducted using pCR and non remission as dependent variables and TNM stage,Ktrans,Ve,and Kep as independent variables.The results showed that TNM stage[95%CI:(1.076-2.611)],Ktrans[95%CI:(1.120-1.678)],Ve[95%CI:(1.253-2.479)],and Kep 95%CI(1.295-1.963)]were independent risk factors affecting pCR(P<0.01);The ROC results showed that Ktrans+Ve+Kep predicted an AUC value of 0.879 for pCR,which was higher than Krans,Ve,and Kep tested separately(P<0.05).Conclusion There were significant changes in the quantitative parameters Ktrans,Ve,and Kep of DCE-MRI before and after NAC treatment,which showed lower levels in pCR patients after NAC treatment;Obtaining DCE-MRI imaging data to predict pCR after NAC treatment is highly feasible and beneficial for guiding clinical improvement of individualized treatment plans in the future.

Dynamic Enhanced Magnetic ResonanceBreast CancerNeoadjuvant ChemotherapyPathology in Complete Remission

王巍巍、刘艳超、李颖、王琪、杨素君

展开 >

邯郸市中心医院CT室(河北邯郸 056008)

邯郸市中心医院超声科(河北邯郸 056008)

动态增强磁共振 乳腺癌 新辅助化疗 病理完全缓解

邯郸市科学技术研究与发展计划项目任务合同

1823208034ZC

2024

中国CT和MRI杂志
北京大学深圳临床医学院 北京大学第一医院

中国CT和MRI杂志

CSTPCD
影响因子:1.578
ISSN:1672-5131
年,卷(期):2024.22(7)
  • 13